However, acute exogenous LEAP2 administration in men without obesity, to increase plasma LEAP2 to ∼2.6 times normal when fed, did not alter plasma AG, though this could be a dose or duration effect rather than species difference [13]. Here, LEAP2 is linked to obesity due to melanocortin 4 receptor deficiency.